
Harms weigh: AstraZeneca vaccine fears
The Intelligence from The Economist
00:00
Intro
This chapter explores the backlash against the Oxford-AstraZeneca COVID-19 vaccine following reports of adverse effects, leading to suspensions in multiple European nations. It underscores the impact of these decisions on vaccination efforts amid escalating infection rates and highlights the urgency of restoring public confidence in vaccines.
Transcript
Play full episode